Mindfulness and Yoga Therapy for Acute Pain in Sickle Cell Disease
1 other identifier
interventional
39
1 country
1
Brief Summary
Patients with sickle cell disease suffer from acute and chronic pain that diminishes their quality of life. The purpose of this study is to assess the feasibility and acceptability of mindfulness meditation, breathing exercises, and gentle yoga therapy as supportive measures for the management of acute vaso-occlusive pain crises in the inpatient setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 19, 2022
CompletedFirst Posted
Study publicly available on registry
October 7, 2022
CompletedStudy Start
First participant enrolled
November 10, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 2, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 2, 2023
CompletedFebruary 13, 2023
February 1, 2023
3 months
September 19, 2022
February 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Feasibility of the intervention as measured by the proportion of sickle cell patients admitted over a consecutive 12 week time period who agree to participate in the study
12 weeks
Feasibility of the intervention as measured by the proportion of participants who accessed the mindfulness videos during their hospitalization
12 weeks
Acceptability of the intervention as measured by the proportion of participants who found the mindfulness practices enjoyable and/or helpful
This data will be collected via a post-intervention survey and interview. The survey will contain simple questions with yes/no answer options. The interview will be conducted by a study member, either in-person or by telephone.
at the time of hospital discharge, up to 6 months post-intervention
Acceptability of the intervention as measured by the proportion of participants who are interested in pursuing mindfulness therapies in the future
This data will be collected via a post-intervention survey and interview. The survey will contain simple questions with yes/no answer options. The interview will be conducted by a study member, either in-person or by telephone.
at the time of hospital discharge, up to 6 months post-intervention
Participant engagement as measured by the number of mindfulness videos watched by each participant during their hospitalization
at the time of hospital discharge, up to 6 months post-intervention
Participant engagement as measured by the percentage of videos completed. A video is considered completed if the participant watches more than 85% of the video.
at the time of hospital discharge, up to 6 months post-intervention
Study Arms (1)
Mindfulness and Yoga Therapy
EXPERIMENTALParticipants will have access to video-guided mindfulness interventions.
Interventions
Sickle cell patients admitted with a vaso-occlusive pain crisis over a consecutive 12-week period will be offered participation in the study. After providing informed consent, participants will have access to 4 videos containing guided mindfulness meditation, breathing exercises, and gentle yoga therapy. The videos are 5-12 minutes long and taught by a physical therapist who is also certified in yoga therapy. Participants may turn off the video at any time. Participants will have access to the videos for the duration of their hospitalization, and they may watch the videos as many times as they desire.
Eligibility Criteria
You may qualify if:
- Patients with sickle cell disease, any genotype
- Adult patients at least 18 years of age
- English speaking
- Admitted to Clements University Hospital with an acute vaso-occlusive pain crisis
You may not qualify if:
- Unable to follow simple instructions
- Admitted to the intensive care unit
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Siayareh Rambally, M.D.
University of Texas Southwestern Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 19, 2022
First Posted
October 7, 2022
Study Start
November 10, 2022
Primary Completion
February 2, 2023
Study Completion
February 2, 2023
Last Updated
February 13, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share